LEADER 01532oam  2200397   450 
001 9910704460403321
005 20130523100757.0
035   $a(CKB)5470000002441090
035   $a(OCoLC)829388042
035   $a(EXLCZ)995470000002441090
100   $a20130308d2013      ua             0
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aDrug Enforcement Administration $ehearing before the Subcommittee on Crime, Terrorism, and Homeland Security of the Committee on the Judiciary, House of Representatives, One Hundred Twelfth Congress, second session, June 20, 2012
210  1$aWashington :$cU.S. Government Printing Office,$d2013.
215   $a1 online resource (iii, 49 pages)
300   $aTitle from title screen (viewed on March 8, 2013).
300   $aPaper version available for sale by the Superintendent of Documents, United States Government Printing Office.
300   $a"Serial no. 112-156."
517   $aDrug Enforcement Administration 
606   $aDrug control$zUnited States$xEvaluation
606   $aDrug traffic$zMexican-American Border Region
607   $aMexico$xForeign relations$zUnited States
607   $aUnited States$xForeign relations$zMexico
615  0$aDrug control$xEvaluation.
615  0$aDrug traffic
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910704460403321
996   $aDrug Enforcement Administration$93474293
997   $aUNINA